Search

everythinglearnresearchcommunity

for

Search:↓

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Scalp cooling effectively reduces hair loss from chemotherapy.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Sodium valproate can cause reversible hair loss in some patients.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Sertraline can cause hair loss, which stops after stopping the drug.

New treatments for hair loss are being developed using molecular biology.

Pressure-induced hair loss is rare, often reversible, and early diagnosis is crucial to prevent complications.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

New alopecia treatments aim for better results and fewer side effects.